M. Udvardy

2.3k total citations
99 papers, 1.6k citations indexed

About

M. Udvardy is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, M. Udvardy has authored 99 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Hematology, 18 papers in Genetics and 18 papers in Immunology. Recurrent topics in M. Udvardy's work include Platelet Disorders and Treatments (17 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers) and Complement system in diseases (11 papers). M. Udvardy is often cited by papers focused on Platelet Disorders and Treatments (17 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers) and Complement system in diseases (11 papers). M. Udvardy collaborates with scholars based in Hungary, United States and Germany. M. Udvardy's co-authors include I Altorjay, Jolán Hársfalvi, Mária Papp, Péter L. Lakatos, Károly Palatka, János Kappelmayer, István Tornai, Zsuzsanna Vitális, Gábor Veres and Kálmán Rák and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Gastroenterology.

In The Last Decade

M. Udvardy

93 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Udvardy Hungary 23 431 406 380 353 239 99 1.6k
Kiyoaki Watanabe Japan 27 762 1.8× 219 0.5× 283 0.7× 152 0.4× 259 1.1× 72 1.8k
Graham Hughes United Kingdom 22 673 1.6× 274 0.7× 1.6k 4.3× 268 0.8× 249 1.0× 49 3.8k
Søren Thue Lillevang Denmark 27 176 0.4× 351 0.9× 606 1.6× 333 0.9× 79 0.3× 91 2.3k
Myriam Labalette France 29 357 0.8× 401 1.0× 1.0k 2.7× 152 0.4× 135 0.6× 150 2.3k
Jennifer Schneiderman United States 15 732 1.7× 156 0.4× 484 1.3× 128 0.4× 186 0.8× 45 1.9k
Seiji Madoiwa Japan 24 864 2.0× 556 1.4× 429 1.1× 343 1.0× 269 1.1× 92 2.5k
Petra Stohlawetz Austria 22 748 1.7× 329 0.8× 301 0.8× 83 0.2× 167 0.7× 37 1.7k
Shane M. Meehan United States 27 192 0.4× 277 0.7× 769 2.0× 179 0.5× 548 2.3× 57 3.4k
Shifra Ash Israel 22 145 0.3× 290 0.7× 176 0.5× 143 0.4× 284 1.2× 86 1.6k
Allan Sturgess Australia 21 156 0.4× 388 1.0× 384 1.0× 141 0.4× 138 0.6× 42 1.6k

Countries citing papers authored by M. Udvardy

Since Specialization
Citations

This map shows the geographic impact of M. Udvardy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Udvardy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Udvardy more than expected).

Fields of papers citing papers by M. Udvardy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Udvardy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Udvardy. The network helps show where M. Udvardy may publish in the future.

Co-authorship network of co-authors of M. Udvardy

This figure shows the co-authorship network connecting the top 25 collaborators of M. Udvardy. A scholar is included among the top collaborators of M. Udvardy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Udvardy. M. Udvardy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gergely, Lajos, M. Udvardy, & Árpád Illés. (2024). The Possible Role of Pathogens and Chronic Immune Stimulation in the Development of Diffuse Large B-Cell Lymphoma. Biomedicines. 12(3). 648–648. 3 indexed citations
2.
Szász, Róbert, et al.. (2023). Autologous Transplantation May Still Effectively Treat Relapsed Diffuse Large B-Cell Lymphoma in Selected Patients. Cancers. 15(12). 3223–3223. 1 indexed citations
3.
Illés, Árpád, M. Udvardy, Zoltán Prohászka, et al.. (2022). Von Willebrand Factor and Platelet Levels before Conditioning Chemotherapy Indicate Bone Marrow Regeneration following Autologous Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 28(12). 830.e1–830.e7.
4.
Udvardy, M., Mária Papp, Jolán Hársfalvi, et al.. (2016). Evaluation of Mannose-Binding Lectin is a Useful Approach to Predict the Risk of Infectious Complications Following Autologous Hematopoietic Stem Cell Transplantation. Transplantation Proceedings. 48(10). 3397–3405. 3 indexed citations
5.
Szász, Róbert, Ildikó Beke Debreceni, Péter Batár, et al.. (2012). Comparison of coated-platelet levels in patients with essential thrombocythemia with and without hydroxyurea treatment. Platelets. 24(6). 486–492. 6 indexed citations
6.
Lakatos, Péter L., Lajos S. Kiss, Károly Palatka, et al.. (2010). Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohnʼs disease. Inflammatory Bowel Diseases. 17(3). 767–777. 69 indexed citations
7.
Papp, Mária, Péter L. Lakatos, Jolán Hársfalvi, et al.. (2010). Mannose-binding lectin level and deficiency is not associated with inflammatory bowel diseases, disease phenotype, serology profile, and NOD2/CARD15 genotype in a large Hungarian cohort. Human Immunology. 71(4). 407–413. 12 indexed citations
8.
Papp, Mária, Zsuzsanna Vitális, István Tornai, et al.. (2010). M1675 Presence of Anti-Microbial Antibodies is Associated With Increased Risk for Systemic Infections in a Large Hungarian Cohort of Patients With Liver Cirrhosis. Gastroenterology. 138(5). S–827. 2 indexed citations
9.
Kappelmayer, János, M. Udvardy, & Péter Antal‐Szalmás. (2007). Pgp and FLT3: Identification and Modulation of Two Proteins that Lead to Chemotherapy Resistance in Acute Myeloid Leukemia. Current Medicinal Chemistry. 14(5). 519–530. 6 indexed citations
10.
Végh, Judit, Péter Szodoray, János Kappelmayer, et al.. (2006). Clinical and Immunoserological Characteristics of Mixed Connective Tissue Disease Associated with Pulmonary Arterial Hypertension. Scandinavian Journal of Immunology. 64(1). 69–76. 40 indexed citations
11.
Palatka, Károly, Zoltán Serfözö, Zoltán Veréb, et al.. (2005). Changes in the expression and distribution of the inducible and endothelial nitric oxide synthase in mucosal biopsy specimens of inflammatory bowel disease. Scandinavian Journal of Gastroenterology. 40(6). 670–680. 48 indexed citations
12.
Pósán, Emőke, L Gáspár, Zoltán Csernátony, et al.. (2003). Thrombotic and fibrinolytic alterations in the aseptic necrosis of femoral head. Blood Coagulation & Fibrinolysis. 14(3). 243–248. 15 indexed citations
13.
Káplár, Miklós, et al.. (2001). The possible association of in vivo leukocyte-platelet heterophilic aggregate formation and the development of diabetic angiopathy. Platelets. 12(7). 419–422. 53 indexed citations
14.
15.
Pósán, Emőke, et al.. (1998). Reduced In Vitro Clot Lysis and Release of More Active Platelet PAI-1 in Polycythemia Vera and Essential Thrombocythemia. Thrombosis Research. 90(2). 51–56. 26 indexed citations
16.
Pósán, Emőke, et al.. (1998). Increased platelet activation and decreased fibrinolysis in the pathogenesis of aseptic necrosis of the femoral head. Platelets. 9(3-4). 233–235. 7 indexed citations
17.
Udvardy, M., Emőke Pósán, & Jolán Hársfalvi. (1995). Altered lysis resistance of platelet-rich clots in patients with insulin-dependent diabetes mellitus. Thrombosis Research. 79(1). 57–63. 5 indexed citations
18.
19.
Udvardy, M., et al.. (1994). Cyclic relapses of thrombotic thrombocytopenic purpura. Blood Coagulation & Fibrinolysis. 5(2). 305–308. 3 indexed citations
20.
Udvardy, M., et al.. (1987). Plasma thromboxane and prostacyclin metabolite ratio in atherosclerosis and diabetes mellitus. Thrombosis Research. 47(4). 479–484. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kiyoaki Watanabe Breakdown of academic impact, for papers by Graham Hughes Breakdown of academic impact, for papers by Søren Thue Lillevang Breakdown of academic impact, for papers by Myriam Labalette Breakdown of academic impact, for papers by Jennifer Schneiderman Breakdown of academic impact, for papers by Seiji Madoiwa Breakdown of academic impact, for papers by Petra Stohlawetz Breakdown of academic impact, for papers by Shane M. Meehan Breakdown of academic impact, for papers by Shifra Ash Breakdown of academic impact, for papers by Allan Sturgess
Rankless by CCL
2026